You are currently using an unsupported browser which could affect the appearance and functionality of this website. Please consider upgrading to the latest version or using alternatives such as Mozilla Firefox, Google Chrome or Microsoft Edge.

Stem Cell Therapies in Obstetrics and Gynaecology (Scientific Impact Paper No. 38)


This paper recognises that reproductive and fetal tissues are sources of stem cells and targets for regenerative medicine.

Such treatments in gynaecology are still in the preclinical and clinical phases, and the field of obstetrics has primarily focused on these interventions for fetal therapies. This paper discusses the possibilities, progress and problems of regenerative medicine to the genital tract and stem cell treatment of genetic diseases.

The paper also acknowledges the ethical issues and unknown risks and limitations that have arisen within this area.

COVID disclaimer

This Scientific Impact Paper was developed prior to the emergence of the COVID-19 coronavirus.

Version history

This is the first edition of this Scientific Impact Paper.

Please note that the Scientific Advisory Committee regularly assesses the need to update. Further information on this review is available on request.

Developer declaration of interests

Available on request.

This page was last reviewed 22 May 2013.